FDA Slaps Boxed Warning on Osteoporosis Drug

(MedPage Today) -- The FDA added a boxed warning to the label of the osteoporosis drug denosumab (Prolia) over the risk of severe hypocalcemia in patients with advanced chronic kidney disease (CKD), the agency announced Friday. After a review...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news